CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ANNX — Annexon, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,107,545
+$801,104 QoQ
Shares Held
1,102,445
+4.3% QoQ
Ownership
0.552%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. ANNX ranks #123 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,107,545 | 1,102,445 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,306,441 | 1,057,060 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,410,262 | 790,250 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,748,133 | 728,389 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,400,701 | 725,752 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,815,668 | 743,795 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,334,718 | 732,216 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,115,044 | 227,560 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,298,135 | 181,051 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $561,452 | 123,668 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $291,856 | 123,668 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $435,311 | 123,668 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $74,428 | 19,332 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $99,946 | 19,332 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $119,471 | 19,332 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $445,512 | 118,173 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $515,197 | 188,717 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,239,998 | 194,952 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,553,151 | 190,927 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,170,871 | 140,865 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,589,104 | 128,919 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,586,124 | 103,321 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,889,474 | 95,583 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||